| Kelly, Andrea |
NCT04731272: GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance |
|
|
| Recruiting | 2 | 30 | US | Dulaglutide 0.75Mg/0.5Ml Inj Pen | University of Pennsylvania, Children's Hospital of Philadelphia | Cystic Fibrosis, Pancreatic Insufficiency, Abnormal Glucose Tolerance, Diabetes | 06/26 | 06/27 | | |
NCT01851694: Beta-cell Response to Incretin Hormones in Cystic Fibrosis |
|
|
| Recruiting | N/A | 45 | US | GLP-1, GIP, Glucose-dependent insulinotrophic polypeptide | University of Pennsylvania, Children's Hospital of Philadelphia | Cystic Fibrosis, Pancreatic Insufficiency | 12/25 | 12/25 | | |
NCT05568134: Alternate Measures of Glucose During OGTT Testing for CFRD |
|
|
| Recruiting | N/A | 30 | US | Oral glucose tolerance test | Children's Hospital of Philadelphia, Cystic Fibrosis Foundation | Cystic Fibrosis, Cystic Fibrosis-related Diabetes | 02/25 | 02/26 | | |
NCT01852448: Genetics of Insulin and Incretins in Cystic Fibrosis |
|
|
| Recruiting | N/A | 550 | US | Blood or Saliva Sample Collection | Children's Hospital of Philadelphia, University of Pennsylvania | Cystic Fibrosis | 07/25 | 07/25 | | |
| Kubrak, Christina |
NCT04171817: Animal-Assisted Visitation Program Chlorhexidine Trial |
|
|
| Recruiting | 4 | 412 | US | Chlorhexidine, CHX | Johns Hopkins Bloomberg School of Public Health, Children's Hospital of Philadelphia, University of Pennsylvania, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Methicillin-resistant Staphylococcus Aureus, Clostridium Difficile, Pseudomonas Aeruginosa | 12/24 | 12/25 | | |
| Walega, Rachel |
NCT06046820: The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency |
|
|
| Recruiting | 3 | 33 | Europe, Canada, US, RoW | INZ-701, (rhENPP1-Fc)., Control Arm (Conventional Therapy) | Inozyme Pharma | Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial Calcification of Infancy | 05/25 | 06/25 | | |
ENERGY, NCT05734196: The Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency |
|
|
| Recruiting | 1 | 16 | Europe, US | INZ-701, (rhENPP1-Fc). | Inozyme Pharma | Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial Calcification of Infancy, ATP-Binding Cassette Subfamily C Member 6 Deficiency, Pseudoxanthoma Elasticum | 03/26 | 04/26 | | |
NCT01852448: Genetics of Insulin and Incretins in Cystic Fibrosis |
|
|
| Recruiting | N/A | 550 | US | Blood or Saliva Sample Collection | Children's Hospital of Philadelphia, University of Pennsylvania | Cystic Fibrosis | 07/25 | 07/25 | | |
